Market Place
Sourcing Support
Samsung Invests in Biomedicines for AI-Driven Protein Discovery
18 Dec 2024 //
PR NEWSWIRE
Samsung Biologics Listed Among Most Sustainable in Dow Jones Index
16 Dec 2024 //
PR NEWSWIRE
Samsung Hosts ESG Event to Boost Supplier Decarbonization
03 Dec 2024 //
PRESS RELEASE
Samsung Biologics Signs Manufacturing Deal with European Pharma
19 Nov 2024 //
PR NEWSWIRE
Samsung Biologics Earns ISO Certifications for Business Excellence
08 Nov 2024 //
PR NEWSWIRE
Samsung Biologics reports third quarter 2024 financial results
23 Oct 2024 //
PR NEWSWIRE
Samsung Biologics bags $1.2B production contract
23 Oct 2024 //
FIERCE PHARMA
Samsung Biologics Signs Largest Manufacturing Deal In Asia
21 Oct 2024 //
PR NEWSWIRE
Samsung Biologics Launches High-Concentration Platform
15 Oct 2024 //
PR NEWSWIRE
Samsung Biologics Launches Enhanced Therapeutic Platforms
25 Sep 2024 //
PR NEWSWIRE
Amgen sues Samsung biotech unit over bone drug copies
14 Aug 2024 //
REUTERS
Samsung Biologics Joins Pharmaceutical Supply Chain Initiative
06 Aug 2024 //
PR NEWSWIRE
Samsung Biologics Reports Record Quarter Due To Biosimilar Sales
24 Jul 2024 //
FIERCE PHARMA
FDA Issues Form 483 to Samsung Biologics
15 Jul 2024 //
FDA
FDA Issues Form 483 to Samsung Biologic
11 Jul 2024 //
FDA
Samsung Biologics lands record $1.06B contract with US pharma company
03 Jul 2024 //
FIERCE PHARMA
Samsung Biologics upgrades another production pact, with Baxter for $223M
20 Jun 2024 //
FIERCE PHARMA
Samsung Biologics Way to reinforce innovative & inclusive organizational culture
19 Jun 2024 //
PRESS RELEASE
Samsung Biologics to attend 2024 BIO International Convention
26 May 2024 //
PRESS RELEASE
Samsung Biologics achieves record Q1 earnings
30 Apr 2024 //
FIERCE PHARMA
Samsung Bio’s bet on Plant 4 continues to pay off with 1Q earnings growth
24 Apr 2024 //
ENDPTS
Samsung Biologics Reports First Quarter 2024 Financial Results
24 Apr 2024 //
PR NEWSWIRE
Samsung Biologics recognized for service excellence as it receives CDMO Awards
21 Mar 2024 //
PRESS RELEASE
Samsung Biologics hosts 13th Annual General Meeting of Shareholders
15 Mar 2024 //
PRESS RELEASE
Samsung Biologics signs MOU with Seoul National University to foster bio experts
28 Feb 2024 //
PRESS RELEASE
Samsung Biologics awarded Leadership status by CDP for climate action efforts
13 Feb 2024 //
PR NEWSWIRE
Samsung Biologics partners with LegoChem for ADC development and manufacturing
07 Feb 2024 //
PR NEWSWIRE
With record year, Samsung Bio bucks CDMO industry`s tough 2023
25 Jan 2024 //
FIERCE PHARMA
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results
24 Jan 2024 //
PR NEWSWIRE
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results
23 Jan 2024 //
PRESS RELEASE
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
22 Jan 2024 //
PR NEWSWIRE
Samsung Biologics presents 2024 business plans at J.P. Morgan Conference
09 Jan 2024 //
PR NEWSWIRE
Samsung Biologics engages suppliers to advance global decarbonization targets
28 Nov 2023 //
PR NEWSWIRE
Samsung eyes expansion; and supply chain diversification
27 Oct 2023 //
ENDPTS
Thermo Fisher grows into CGT manufacturing, while Samsung expands into ADCs
26 Oct 2023 //
ENDPTS
Samsung Biologics reports third quarter 2023 financial results
25 Oct 2023 //
PR NEWSWIRE
Samsung adds another Lucentis interchangeable biosimilar to the mix
24 Oct 2023 //
ENDPTS
Samsung Biologics and Kurma Partners announce strategic partnership
23 Oct 2023 //
PR NEWSWIRE
Samsung`s biologics plant in South Korea receives Form 483
19 Oct 2023 //
ENDPTS
FDA Issues Form 483 to Samsung Biologics Co. Ltd.
17 Oct 2023 //
FDA
Samsung adds to BMS partnership with $242M antibody agreement
18 Sep 2023 //
FIERCE PHARMA
Samsung Biologics announces expanded strategic agreement with BMS
17 Sep 2023 //
PR NEWSWIRE
Samsung Biologics Enters Research Collaboration with AimedBio
13 Sep 2023 //
CONTRACT PHARMA
Samsung Biologics appoints leadership to oversee quality and regulatory affairs
23 Aug 2023 //
PR NEWSWIRE
Samsung Biologics Reports Second Quarter 2023 Financial Results
26 Jul 2023 //
PR NEWSWIRE
Samsung Biologics releases 2023 ESG Report
18 Jul 2023 //
PR NEWSWIRE
Samsung Biologics inks another lucrative pharma production pact
10 Jul 2023 //
FIERCE PHARMA
Samsung Biologics partners with Pfizer for biosimilars production
09 Jun 2023 //
THE PHARMA LETTER
Samsung Biologics moves up plans to open its $1.5B+ plant
06 Jun 2023 //
ENDPTS
Samsung Biologics to attend 2023 BIO International Convention
30 May 2023 //
PRESS RELEASE
Samsung Biologics Reports First Quarter 2023 Financial Results
24 Apr 2023 //
PR NEWSWIRE
Samsung and Sandoz question FDA`s `research roadmap` for biosimilars development
06 Apr 2023 //
ENDPTS
Samsung Biologics hit by series of attempts to steal trade secrets
28 Mar 2023 //
KOREA TIMES
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
17 Mar 2023 //
PR NEWSWIRE
Pfizer inks $183M contract manufacturing deal with Samsung Biologics
03 Mar 2023 //
FIERCE PHARMA
Samsung Biologics spells out expansion plans in South Korea and US
27 Jan 2023 //
ENDPTS
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
27 Jan 2023 //
PR NEWSWIRE
Samsung Biologics shares business plans at J.P. Morgan Healthcare Conference
12 Jan 2023 //
PRESS RELEASE
Samsung Biologics CEO talks of expansion into production of ADCs
12 Jan 2023 //
FIERCE PHARMA
